Monthly FDA Guidance and Regulatory News Review - August 2026
This August 2026 regulatory update focuses on the FDA finalizing three guidances addressing formal...
This August 2026 regulatory update focuses on the FDA finalizing three guidances addressing formal...
This July 2026 regulatory update focuses on the FDA finalizing six guidances that addresses...
China is rapidly becoming one of the most influential forces in global drug development—but...
AI is changing clinical development, but speed alone isn't enough. In a regulated industry, every...
This June 2026 regulatory update focuses on advancing innovative drug development through updated...
Antibody-drug conjugates — or ADCs — are not new. The concept of a "magic bullet" that delivers a...
Investigational New Drug Applications (INDs) and Clinical Trial Applications (CTAs) are regulatory...
Would your drug development program benefit from partnering with experts in scientific and medical...